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Introduction 
 
Background 
Interest in intravenous fluid therapy escalated after William Harvey first described the human 
circulation in the 17th century.(1) The outbreak of cholera in the 19th century accelerated the 
development of intravenous fluid.(2) One of its pioneers, Dr Lata, experimented with saline based 
intravenous solutions following a letter published by Dr O’Shaughnessy in the Lancet.(3, 4) This period 
not only lead to significant advances in clear intravenous fluid but also saw the first documented 
blood transfusion. Dr J  Blundell, who after conducting animal studies, undertook to transfuse a 
women in haemorrhagic shock following post-partum haemorrhage.(5) These advances in clinical fluid 
therapy continued well into the late 1900’s, with the introduction of various synthetic colloid and 
crystalloid solutions, and numerous blood products.  
Controversies surrounding the use of clear intravenous fluids (synthetic colloids and crystalloids) 
have become prominent in the modern era.  This has been most notable in the comparative use of 
crystalloids and colloids. 
Between 2012 and 2013 a number of trials were published attempting to illuminate the crystalloid 
versus colloid fluid debate. One of the most prominent studies, Myburgh et. al (CHEST trial), 
investigated the safety and efficacy of HES versus 0.9% saline for fluid resuscitation in ICU (6). No 
mortality difference (90-day mortality) was demonstrated between 0.9% saline and HES (6%), 
however, renal replacement therapy requirements were greater in the group who received HES.(6) 
Perner et. al (6S Trial) found higher mortality and renal replacement therapy requirements in patients 
randomised to receive HES (6%) versus Ringers acetate solution in the setting of severe sepsis and 
septic shock.(7) 
The above trials showed a signal of harm with the repeated use of HES in the ICU setting, or at best, 
no significant benefit in resuscitation of ICU patients. The limitations and debates surrounding these 
trials are beyond the scope of this introduction.  
Despite these concerns, various authors demonstrated benefit with the directed and mindful use of 
synthetic colloids in certain population groups . In 2011 James et. al (FIRST trial) showed an 
improved lactate clearance and lower incidence of renal injury in trauma patients resuscitated with 
130/0.4 HES, especially in the penetrating trauma group.(8) 
Guidet et. al (Crystmas trial) randomized patients with severe sepsis to receive either HES (6%) or 
0.9% saline, assessing hemodynamic efficacy and safety. This study concluded that significantly less 
volume was required to achieve hemodynamic stability in the HES group without any difference in 
adverse events. In addition they noted no difference in mortality between crystalloids and colloids at 
28 days and improved mortality at 90 days (relative risk 0.92).(9) 
However, many of the positive trials were small in comparison to the Myburgh and Perner trials, and 
in 2013 The Pharmacovigilance Risk Assessment Committee (PRAC) published an assessment report 
for solutions containing hydroxyethyl starch. Their findings were mostly based on VISEP, 6S, and 
CHEST trials and concluded that HES was associated with increased mortality and renal dysfunction 
in critically ill, septic and burn patients. Short term hemodynamic improvements were noted in other 
patient populations, including surgical and trauma patients.(10) Their recommendation was for the use 
of HES to be restricted to initial volume resuscitation in patients with hypovolaemia due to acute 
blood loss where crystalloids alone are not sufficient, and should be restricted to a maximum of 24 
hours. In the most recent review done by the Cochrane group on fluid resuscitation in the critically ill, 
mortality was found to be similar between patients receiving colloids and crystalloids.(11) Most notable 
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though, HES did increase need for renal replacement therapy and increase need for blood transfusion 
with moderate level of certainty.(11) 
Evaluating the translation of research into clinical practice regarding the use of intravenous fluid is a 
challenging endeavour. Two large trials attempted to address these questions. Finfer et. al published 
the SAFE-TRIPS trial in 2007. This cross-sectional study conducted in 391 intensive care units across 
25 countries (RSA was excluded) described different types of fluid used during resuscitation. The 
main indication for fluid was the correction of impaired perfusion and abnormal vital signs. Although 
intravenous fluid administration was a common intervention, the choice of fluid varied markedly 
between countries.(12) This study indicated a prevalence towards using more 0.9% saline and colloid 
solutions. 
In 2014, the Fluid-Trips trial evaluated the use of fluid during a 24hour period in 27 countries and 
included 426 intensive care units. The study included 6707 patients of whom 1456 received 
resuscitative fluid. Crystalloids where administered in 81.3% and colloids in 27.1% of the episodes. 
This was a marked change from practice noted in 2007 where colloids were used in 62% of the cases. 
There was still significant geographic variation.(13) When comparing fluid usage during resuscitation, 
it was recognised that more balanced isotonic crystalloids (such as ringers lactate) where used as 
opposed to synthetic colloids and unbalanced solutions (such as 0.9% saline). This comparison 
potentially indicates translation of evidence into practice from 2007 to 2014, although this conclusion 
should be seen as guarded.  
We know very little about current intravenous fluid practice in South Africa as none of the 
translational trials have evaluated this in our country. Fluid management influences patient outcome 
and it is important to understand how fluids are being used peri-operatively, and whether their use is 
appropriate in South Africa (11, 14, 15).  
Aims 
This study aimed to describe the peri-operative use of synthetic intravenous fluid by peri-operative 
physicians in South Africa. The secondary aims included identifying institutional and interdisciplinary 
differences in fluid management during the peri-operative period, and areas for future research. 
Methods  
Design 
This was an observational cohort questionnaire study conducted between September 2016 and May 
2017. An interactive online survey with 23 questions was created using Google forms. The link to the 
survey was sent to participants via email through supporting societies and university departments. To 
improve the number of participants reached in the various sectors of anaesthesia, the link was 
distributed to members of the South African Society of Anaesthesiology (SASA) via the SASA 
weekly newsletter.  
Study population 
The study population was physicians involved in peri-operative patient management. The survey was 
distributed to various disciplines considered to be involved in peri-operative patient management, and 
included emergency medicine, anaesthesia, and critical care. However, the majority of responses 
came from doctors working in anaesthesia.  
Questionnaire development and testing 
The questionnaire was constructed to assess how the different types of fluid used in commonly 
encountered peri-operative scenarios. The survey focussed on three areas: (i) demographics;  (ii) type 
of fluids used; and (16) fluid management practices. Simplified and directed questions were created to 
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avoid ambiguity and decrease bias. We were unable to find previous studies addressing similar 
questions. We were unable to construct the questions using validated questions as there was little 
published data addressing these concerns. Following the questionnaire construction, it was sent to 4 
independent medical practitioners for comments and testing. After revisions and retesting, the 
questionnaire was distributed.   
Questionnaire administration 
The information page, as well as the link to the survey, was sent to representatives at academic centres 
around South Africa for further distribution to members of their respective departments. The 
information page contained background, consent and ethics information. Consent was required on the 
electronic survey to proceed to the questionnaire. After the initial email, a waiting period of 6 weeks 
was given for correspondents to complete the survey. Following the waiting period, it was 
redistributed to the afore mentioned departments and the survey link included in the SASA weekly 
newsletter. We were unable to personalize emails because we were not given access to email 
databases from the supporting societies or university departments.  
Data analyses 
The data was analysed using the Statistical Package for the Social Sciences (SPSS) version 21 (SPSS 
Inc., Chicago, IL, USA). The descriptive statistics included mean, mode, standard deviation and 
variance per question. These descriptive statistics served to confirm the graphical statistics. The 
categorical data was evaluated using the 2-sided Pearson Chi-Square test.  A P-value of 0.05 was used 
to indicate statistical significance. The survey consisted of 23 questions (detailed in Appendix 1) 
Based on the results of these questions an average score for the correct answers could be calculated 
(expressed as percentage).  Subgroup analyses were performed based on provinces, primary specialty, 
and experience classified in years. 
We highlighted 6 questions that would address our primary and secondary aims. These results were 
assessed using statistical analysis. To make the statistical analysis more focussed, some of the 
responses were amalgamated into main groups. These included demographic data and types of fluid 
used. 
Bias 
Multiple areas have been identified for the potential risk for bias. These are addressed in the limitation 
section.  
Ethics 
Permission for conducting this study was granted by the Health research ethics committee (HREC Ref 
no. 611/2016).  Consent was granted by the participant by agreeing to start survey and this was 
mentioned in the front page of the survey. All responses were confidential as no identifying 
information such as name, email address or IP address were captured. 
 
Results 
During the study period three hundred valid questionnaires where completed. No partially completed 
surveys were identified and none were excluded. We were unable to calculate the response rate due to 
the unknown distribution numbers of the SASA newsletter and the fluctuating number of members in 
the academic centres. Six questions were highlighted as most relevant to answering the question of 
peri-operative fluid use by the peri-operative physician. 
Respondents classified themselves as specialists 204/300(68%), registrars 73/300(24%) or medical 
officers 23/300(8%). 
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Figure 1. Demographics 
 
Interdisciplinary distribution noted 272/300(91%) from anaesthesiology, 13/300(4%) from emergency 
medicine, 13/300(4%) from critical care and 2/300(1%) from other disciplines. 
Figure 2. Area specific distribution 
 
 
Questions: 
 
1. What fluids do you initially use (in your current practice) during resuscitation of a 
haemodynamically unstable trauma patient? 
 
Crystalloids were the fluid of choice for most respondents and did not differ between specialities or 
levels of experience (Figure 3). Some variation did exist among those not choosing crystalloids with 
19/300 (6%) advocating the use of blood products and 48/300 (16%) suggesting synthetic colloids.  
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Differences between provinces were noted with 222/300 (74%) of respondents in the Western cape 
and KwaZulu Natal preferring crystalloids. Gauteng and other provinces choose crystalloids 81% and 
92% of the time respectively (p=0,035). 
Figure 3. Unstable trauma patient (current practice) 
 
2. What fluids would you like to use (in your current practice) during resuscitation of a 
haemodynamically unstable trauma patient? 
This question was asked to determine the respondent’s preferred fluid, during this clinical scenario, 
because specific products (both synthetic fluids and blood products) are not always available.  
 
Figure 4. Unstable trauma patient (ideal practice) 
 
 
Significant differences were noted between anaesthesia and non-anaesthesia providers with most of 
the anaesthesia respondents 152/272 (59%) preferring crystalloids. In contrast, non-anaesthesia 
providers preferred using blood products (p=0,046). A third of anaesthesia providers 90/272 (33%) 
chose blood products as their first choice. 
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Albumin and synthetic colloids were proposed the least by all respondents. Doctors from other 
medical specialities suggested their preferred choice of fluid were blood products 17/28 (61%), 
crystalloids 8/28 (29%), and synthetic colloids 3/28 (10%). 
3. If you find your patient (who has a normal haemoglobin) unresponsive to initial chosen fluid, 
what is your preferred fluid? 
Figure 5. Non-anaemic trauma patient. 
 
The choice of fluids for non-anaemic hypovolaemic trauma patients is shown in figure 5. A large 
variance was noted between anaesthetic and non-anaesthetic respondents (p=0,001). Nearly two thirds 
(63%) of anaesthesia providers preferred synthetic colloids in this scenario. Blood products were 
suggested by just less than half (46%) of non-anaesthesia providers and only one third (32%) 
preferred synthetic colloids. Only 10/300 (3%) respondents chose albumin or hypertonic saline for 
these patients. 
4. If you find your patient (who has a low haemoglobin) unresponsive to initial chosen fluid do 
you consider changing to one of the following? 
Figure 6. Anaemic trauma patient 
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There were very few respondents that did not prefer using blood products for anaemic hypovolaemic 
trauma patients (figure 6). 
5. What is your choice of fluid when resuscitating a hemodynamically unstable SEPTIC 
patient? 
Figure 7 illustrates the choices of intravenous fluids used during resuscitation of the unstable septic 
patient. Most respondents opted for crystalloids 205/300 (68%). However, synthetic colloids were 
suggested by 47/300 (16%) of respondents, and of those, 34/47 (72%) were specialists. The 
distribution was relatively similar between both anaesthetic and non-anaesthetic providers.  
Figure 7. Septic shock patient
 
 
Discussion 
Intravenous fluid management has undergone intense scrutiny in recent times with various attempts 
being made to understand their optimal use. Concerns regarding the use of certain types fluids have 
been highlighted. Most notable the CHEST, 6S and VISEP trials found a signal of harm with the use 
of synthetic colloids in certain pathologies.(6, 7, 11, 14) Brunkhorst et. al (VISEP trial) evaluated the use 
of synthetic colloids in comparison to crystalloids. The study did a two by two factorial comparison 
using pentastarch (10%), not used anymore, or modified Ringers Lactate. They concluded that the use 
of 10% hydroxyethyl starch (HES) was harmful, with increased renal impairment and a dose-
dependent effect on 90-day mortality.(17) HES containing colloids have been implicated with the 
increased need for renal replacement therapy and potentially the increased requirement for blood 
transfusion, especially in septic patients.(11, 14) Although not all colloids have a similar risk profiles(11). 
In 2004, Finfer et. al (SAFE trial) showed 28-day intensive care unit (ICU) mortality to be similar 
following administration of either 0.9% saline and 4 % albumin.(18) A more recent meta-analysis done 
by the Cochrane group found no difference in mortality but a likely increased need for renal 
replacement therapy after administration of HES.(11) Smaller studies, including the FIRST and 
CRISTAL trials, demonstrated the benefit of synthetic colloids in certain conditions, especially in the 
initial resuscitation phase of the acutely hypovolaemic patient.(8, 9) The use of synthetic colloids in the 
setting of acute hypovolaemia leads to less volume being administered, early return of hemodynamic 
stability and earlier lactate clearance.(8) 
6% 10%
67%
1%
16%
4% 0%
86%
0%
11%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
A
lb
u
m
in
B
lo
o
d
 p
ro
d
u
cts (in
clu
d
in
g
free
ze
 d
rie
d
 p
lasm
a/ o
r
fresh
 fro
ze
n
 p
lasm
a)
C
rystallo
id
s
H
yp
erto
n
ic salin
e
Syn
th
e
tic co
llo
id
s
Anaesthesiology
Other (physicians and other medical
disciplines)
   
 
 12 
Despite current evidence of harm associated with inappropriate use, the implementation or translation 
of suggested practices have not been universally adopted. Some evidence indicates that adoption of 
guidelines is being made. The saline versus albumin fluid evaluating translation of research into 
practice trial (SAFE- TRIPS, 2007)(12) and the fluid translation into research trial (Fluid-TRIPS, 
2014)(13) have done this in the ICU setting. They were conducted 7 years apart and found the use of 
crystalloids during the resuscitation episodes in ICU increased from 43% to 72%.(13) It seems likely 
that these changes where due to the research published between 2004 and 2013.(6, 7, 9, 18)  
Importantly the Fluid-TRIPS trial also reflected another change in practice related to recently 
published research, with a trend towards balanced solutions being favoured during resuscitation. In 
2007, 62% of crystalloids used were 0.9% saline, while in 2014 that decreased to 42% with clinicians 
showing preference for more balanced crystalloid solutions(13). This change in practice is likely due to 
evidence demonstrating worse outcome with the use of ‘unbalanced solutions’ such as 0.9% saline.(19) 
These studies attempted to evaluate of adoption or translation of evidence into practice. None of the 
South African centres were involved in this research and we are thus unsure if current practice is 
following international trends and aligning with guidelines. Understanding how peri-operative 
physicians use intravenous fluids is important to determine whether research is being translated into 
appropriate clinical practice.  
Our study showed areas of practice which were similar to the Fluid-TRIPS trial. For example, 67% of 
anaesthesiologists use crystalloids in the resuscitation of the unstable septic patient, which is very 
similar to 72% noted in the Fluid-TRIPS trial. Subgroup analysis of our results did, however, find 
some variation even amongst experienced practitioners. Most variation existed between specialities. 
Anaesthesiologists prefer crystalloids during resuscitation of unstable trauma patients, while most 
non-anaesthesiologists suggested early use of blood products (p=0.001). Less experienced 
practitioners echoed this trend preferring the use of blood products in unstable trauma patients, as 
suggested by 63% of the responding registrars. The timing of blood product administration in trauma 
patients is still controversial.(20, 21) Individualizing patient care was highlighted as important when 
making this decision. For example, a patient presenting with hypotension due to blood loss from a 
peripheral wound that is easily stopped does not need blood products unless clearly indicated, 
presence of low Hb or coagulopathy. When comparing this to a patient with imminent exsanguination 
from severe abdominal or chest trauma needing expedited management who would benefit from early 
use of blood products.(21) The discrepancy between disciplines in our survey, however, is difficult to 
explain. Interpretation of these findings should be taken into context as only 28/300(9%) were from 
non-anaesthetic backgrounds and therefore cannot be regarded as an accurate reflection of practices in 
those specialities.  
Some responses did, however, cause concern and are noted to be in conflict with recent publications. 
Most concerning was the use of colloid based resuscitation by 47/272(16%) of the responding 
anaesthesiologists during resuscitation of unstable septic patients. Current evidence would suggest 
increased risk with this practice, resulting in increased need for renal replacement therapy (6, 7, 17). 
Another example is the 5% of respondents who did not use blood products for unstable trauma 
patients with a low haemoglobin. It should be noted that all these respondents were anaesthesiologists 
with more than 5 years’ experience. Despite these outliers most participants seemed to follow 
recommended practice in both these scenarios. Some variation was noted between disciplines, but the 
distribution was not statistically different (p=0.263). 
Other interesting results included the use of hypertonic saline during resuscitation of the unstable 
trauma patient. Current evidence seems to suggest no benefit from using hypertonic saline in 
comparison to isotonic crystalloids.(22) Recommendations are to reserve hypertonic saline for use in 
managing resuscitation of traumatic brain injuries or correction of hyponatraemia.  
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It was expected that junior participants would follow a more protocolized regime and senior 
participants would show more variety in their choice, since more experienced practitioners are likely 
to have been exposed to different clinical scenarios. It is a common understanding that patients 
behave differently despite having similar pathology, and that holds true even for the same patient 
during the various stages of resuscitation. Despite the differences in managing the unstable trauma 
patient in ideal circumstances there was good agreement between specialist and non-specialists. This 
may reflect teaching practices in the participating areas. No significant variety in practice was noted 
between the different provinces. 
Limitations 
Online survey’s and observational data may reflect knowledge rather than clinical practice. To help 
improve survey correspondence, clear easy to answer questions were used. The study was noted to be 
biased towards physicians with access to the internet and active e-mail addresses. Due to the survey 
being distributed on multiple occasions there was a risk of duplication due to participants completing 
the survey more than once. It must be noted that the information in the online survey might not reflect 
the clinical practice of fluids by the peri-operative physician, but rather a knowledge of its correct use. 
It is hoped, however, that those completing the survey were truthful. Due to distribution being centred 
on anaesthesia, a disproportional number of respondents where from anaesthetic practice.  
Conclusion 
Patterns of fluid use in the resuscitative phase by South African peri-operative physicians appears to 
follow the international trends identified in the Fluid Trips trial.  However, synthetic colloids are used 
in septic patients where evidence suggests otherwise. A lack of access to blood products may 
influence this practice. There are some peri-operative fluid management strategies suggested by 
practitioners that have the potential to cause harm. This highlights the need for continued professional 
development and ongoing attempts to translate important research findings into clinical practice. 
Areas for future research should include a more objective assessment of fluid use, volume status and 
understanding the accurate determination of the amount of fluid to use. Continued education 
focussing specifically on the use of blood products( a limited resource) and the correct use of HES in 
certain population groups is needed.  
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Appendix 1 (Questionnaire) 
 
Peri-operative fluids survey 
Information 
* Required 
Background 
Various aspects of fluid management have become areas of intense research and it is therefore 
important to understand how to appropriately use IV fluid therapy. Understanding the use of 
synthetic fluids by the peri operative physician in the South African context will help identify the 
misunderstanding/misinterpretation of their use. 
Consent 
Your participation in this study is voluntary and will not be penalized. By selecting the agree button 
you are consenting to complete the survey. The survey should take no more than 5-10 minutes to 
complete. Your responses are confidential, and we do not collect identifying information such as 
your name, email address or IP address. All data is stored on a password protected electronic 
format. Should you have any enquiries please contact us at 021 404 5001, D23 Groote Schuur 
Hospital or via the Groote Schuur Hospital switchboard. Should you have any questions about 
your rights regarding research you can contact Human Research Ethics Committee at 021 406 
6338 HREC Ref no. 611/2016. Thank you. 
I have read the above information and in terms of participating * 
Mark only one oval. 
Agree Skip to question 2. 
Disagree Skip to "Please feel free to come back and complete the questionnaire 
later." 
Please feel free to come back and complete the 
questionnaire later. 
Please contact Dr Marcelle Jagga (email address) should you have any questions that may assist 
you in making a decision regarding your involvement. Thank you. 
 
Demographics 
1. What position do you currently hold? * 
Mark only one oval. 
Intern 
Medical officer 
Registrar 
Specialist 
Fellow in subspecialty 
Other: 
2. In which specialty do you spend most of your time? * 
Mark only one oval. 
Anaesthesiology 
Critical care 
Emergency medicine 
Surgery ( all surgical disciplines) 
Other (physicians and other medical disciplines) 
3. Current province where you work? * 
Mark only one oval. 
Eastern Cape 
Free State 
Gauteng 
Kwazulu-Natal 
Limpopo 
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Mpumalanga 
Northern Cape 
North West 
Western Cape 
4. How many years post-graduation have you been working in medicine? * 
Mark only one oval. 
0-5 years 
5-10 years 
More than 10 years 
 
Pertaining to peri-operative fluids: 
5. What fluids DO you initially use (in your current practice) during resuscitation of a 
haemodynamically unstable TRAUMA patient * 
Mark only one oval. 
Crystalloids 
Synthetic colloids 
Blood products (including freeze dried plasma/ or fresh frozen plasma) 
Albumin 
Use "a-c" in descending order 
Use all in descending order 
Other: 
6. What fluids would you LIKE to use (in your current practice) during resuscitation of a 
haemodynamically unstable trauma patient * 
Mark only one oval. 
Crystalloids 
Synthetic colloids 
Blood products (including freeze dried plasma/ or fresh frozen plasma) 
Albumin 
Use "a-c" in descending order 
Use all in descending order 
Other: 
7. If you find your patient (who has a NORMAL haemoglobin) unresponsive to initial 
chosen fluid do you consider changing to one of the following * 
Mark only one oval. 
Crystalloids 
Synthetic colloids 
Blood products (including freeze dried plasma/ or fresh frozen plasma) 
Hypertonic saline 
Albumin 
Stay with initial selection 
Other: 
8. If you find your patient (who has a LOW haemoglobin) unresponsive to initial chosen 
fluid do you consider changing to one of the following * 
Mark only one oval. 
Crystalloids 
Synthetic colloids 
Blood products (including freeze dried plasma/ or fresh frozen plasma) 
Hypertonic saline 
Albumin 
Stay with initial selection 
Other: 
9. Your choice of fluid when resuscitating a hemodynamically unstable SEPTIC patient 
* 
Mark only one oval. 
Crystalloids 
Synthetic colloids 
Blood products (including freeze dried plasma/ or fresh frozen plasma) 
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Hypertonic saline 
Albumin 
Other: 
10. How commonly do you use hydroxyethyl starch (HES) solutions? * 
Mark only one oval. 
Daily 
A few times a week 
A few times a month 
Rarely 
Never 
11. Does your institution use other synthetic colloids * 
Mark only one oval. 
Yes 
No 
12. In what situations would you consider using HES? (Choose all relevant) * 
Check all that apply. 
Hypovolaemic shock 
Septic shock 
Neurogenic shock 
Maintenance fluid 
Co-loading in obstetrics 
Pre-loading in obstetrics 
I'm not quite sure 
Other: 
 
Pertaining to peri-operative fluids (2): 
13. Do you exclude certain patients from receiving a synthetic colloid? * 
Mark only one oval. 
Yes Skip to question 15. 
No Skip to question 16. 
HES choice 
14. Which patients do you exclude from receiving synthetic colloid fluids?(Choose all 
relevant)? * 
Check all that apply. 
ICU/ critically ill patients 
Septic patients 
Burn patients 
Cardiac patients 
Trauma patients 
Paediatric patients 
Obstetric patients 
Renal impairment 
Elderly patients 
All of the above 
Other: 
 
Fluid resuscitation assessment 
15. Choose the best indicator that you use to evaluate your patients need for 
intravenous fluid resuscitation * 
Mark only one oval. 
Low blood pressure 
High lactate 
Worsening base deficit 
Low urine output 
Pulse pressure variation of more than 14% 
IVC collapsibility of more than 50% 
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None of the above 
Other: 
16. What parameters DO you use (in your current practice) in your continued 
assessment of a haemodynamically unstable patient who may require intravenous fluid 
resuscitation? * 
Check all that apply. 
Vital signs 
Capillary refill time 
Central venous pressure 
Glasgow coma scale 
Lactate 
Dynamic indicators 
All of the above 
Other: 
17. Select the best indicator you would LIKE TO USE to allow for continued assessment 
of a hemodynamically unstable patient who may require intravenous fluid resuscitation 
* 
Mark only one oval. 
Vital signs 
Capillary refill time 
Central venous pressure 
Glasgow coma scale 
Lactate 
Dynamic indicators 
All of the above 
Other: 
18. Initial volume of fluid given while resuscitating a haemodynamically unstable 
patient prior to re-assessment? * 
Mark only one oval. 
0-249ml 
250-499ml 
500-1000ml 
more than 1000ml 
19. What do you primarily use to assess if the patient has responded to fluid given 
(choose all relevant)? * 
Check all that apply. 
Improvement in vital signs 
Improvement in lactate, urine output, capillary refill time and GCS 
Dynamic indicators less responsive 
Other: 
20. How often do you reassess the patient during the resuscitative phase? * 
Mark only one oval. 
Continuously 
Every 30 minutes 
Every 2 hours 
After administration of fluid 
When time allows 
Other: 
21. How often are cardiac output monitors applied to patients in your institution? * 
Mark only one oval. 
All haemodynamically unstable patients 
Few selected patients 
No cardiac output monitoring available in your unit 
Unsure 
Other: 
22. If a cardiac output monitor were available (and cost was irrelevant), on which 
patients would you apply them? * 
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Mark only one oval. 
Patients not responding to conventional fluid management 
Patients expected to receive more than 2000ml of intravenous fluid in resuscitation 
All unstable septic patients 
All of the above 
Other: 
Powered by 
23. If you were able to assess the state of the endothelial glycocalyx would you use it to 
change your fluid management? * 
Mark only one oval. 
Yes 
No 
Not sure 
What is the glycocalyx? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
